SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc., today announced it has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD). The new device offers improved ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) - The U.S. health regulator said on ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced publication of a peer-reviewed study supporting its patented blood ...

Boulder-based lung cancer diagnostic company Biodesix recently received a patent for its proprietary blood specimen collection device. The new device enhances ease of use, and reduces cost and ...

We have written at length about the U.S. Food and Drug Administration’s (FDA’s) actions to promulgate regulations specifying the agency’s authority to regulate laboratory developed tests (LDTs) as ...

PHOENIX - A University of Arizona College of Medicine - Phoenix research team has developed a blood self-collection device to quickly estimate a person's exposure to radiation in the event of a ...

Jan 19 (Reuters) - The U.S. health regulator said on Wednesday it was expanding the medical device shortage list to include all blood specimen collection tubes due to supply challenges led by an ...

Findings Suggest Blood Collection Device Simplifies Specimen Collection and Transport While Maintaining Accuracy of Diagnostic Test Results BOULDER, Colo.--(BUSINESS WIRE)-- Biodesix, Inc. (Nasdaq: ...